Style | Citing Format |
---|---|
MLA | Moghadam SS, et al.. "Antibacterial Activity and Toxicity of Zinc Oxide Nanoparticles Combined With Supernatants of Lactobacillus Spp. Against Eskape Bacteria: A Novel Mixture." Iranian Journal of Pharmaceutical Research, vol. 22, no. 1, 2023, pp. -. |
APA | Moghadam SS, Doust RH, Majidpour A, Adabi M, Minaeian S (2023). Antibacterial Activity and Toxicity of Zinc Oxide Nanoparticles Combined With Supernatants of Lactobacillus Spp. Against Eskape Bacteria: A Novel Mixture. Iranian Journal of Pharmaceutical Research, 22(1), -. |
Chicago | Moghadam SS, Doust RH, Majidpour A, Adabi M, Minaeian S. "Antibacterial Activity and Toxicity of Zinc Oxide Nanoparticles Combined With Supernatants of Lactobacillus Spp. Against Eskape Bacteria: A Novel Mixture." Iranian Journal of Pharmaceutical Research 22, no. 1 (2023): -. |
Harvard | Moghadam SS et al. (2023) 'Antibacterial Activity and Toxicity of Zinc Oxide Nanoparticles Combined With Supernatants of Lactobacillus Spp. Against Eskape Bacteria: A Novel Mixture', Iranian Journal of Pharmaceutical Research, 22(1), pp. -. |
Vancouver | Moghadam SS, Doust RH, Majidpour A, Adabi M, Minaeian S. Antibacterial Activity and Toxicity of Zinc Oxide Nanoparticles Combined With Supernatants of Lactobacillus Spp. Against Eskape Bacteria: A Novel Mixture. Iranian Journal of Pharmaceutical Research. 2023;22(1):-. |
BibTex | @article{ author = {Moghadam SS and Doust RH and Majidpour A and Adabi M and Minaeian S}, title = {Antibacterial Activity and Toxicity of Zinc Oxide Nanoparticles Combined With Supernatants of Lactobacillus Spp. Against Eskape Bacteria: A Novel Mixture}, journal = {Iranian Journal of Pharmaceutical Research}, volume = {22}, number = {1}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Moghadam SS AU - Doust RH AU - Majidpour A AU - Adabi M AU - Minaeian S TI - Antibacterial Activity and Toxicity of Zinc Oxide Nanoparticles Combined With Supernatants of Lactobacillus Spp. Against Eskape Bacteria: A Novel Mixture JO - Iranian Journal of Pharmaceutical Research VL - 22 IS - 1 SP - EP - PY - 2023 ER - |